These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23486619)

  • 1. Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease.
    von Volkmann HL; Havre RF; Løberg EM; Haaland T; Immervoll H; Haukeland JW; Hausken T; Gilja OH
    Med Ultrason; 2013 Mar; 15(1):16-22. PubMed ID: 23486619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive quantitative estimation of hepatic steatosis by ultrasound: a comparison of the hepato-renal index and ultrasound attenuation index.
    Kwon HJ; Kim KW; Jung JH; Choi SH; Jeong WK; Kim B; Song GW; Lee SG
    Med Ultrason; 2016 Dec; 18(4):431-437. PubMed ID: 27981274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
    Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
    World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
    J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided B-mode ultrasound diagnosis of hepatic steatosis: a feasibility study.
    Thijssen JM; Starke A; Weijers G; Haudum A; Herzog K; Wohlsein P; Rehage J; De Korte CL
    IEEE Trans Ultrason Ferroelectr Freq Control; 2008; 55(6):1343-54. PubMed ID: 18599422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.
    Zhang B; Ding F; Chen T; Xia LH; Qian J; Lv GY
    World J Gastroenterol; 2014 Dec; 20(47):17985-92. PubMed ID: 25548498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease.
    Akcam M; Boyaci A; Pirgon O; Koroglu M; Dundar BN
    Clin Imaging; 2013; 37(3):504-8. PubMed ID: 23601769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
    Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
    World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis.
    Chauhan A; Sultan LR; Furth EE; Jones LP; Khungar V; Sehgal CM
    J Clin Ultrasound; 2016 Nov; 44(9):580-586. PubMed ID: 27447717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fatty deposits on the accuracy of the Fibroscan® liver transient elastography ultrasound system.
    Cournane S; Browne JE; Fagan AJ
    Phys Med Biol; 2012 Jun; 57(12):3901-14. PubMed ID: 22643042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
    Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
    Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.
    Han A; Zhang YN; Boehringer AS; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    Eur Radiol; 2019 Sep; 29(9):4699-4708. PubMed ID: 30783789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
    Mikolasevic I; Orlic L; Franjic N; Hauser G; Stimac D; Milic S
    World J Gastroenterol; 2016 Aug; 22(32):7236-51. PubMed ID: 27621571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease.
    Mikolasevic I; Orlic L; Zaputovic L; Racki S; Cubranic Z; Anic K; Devcic B; Stimac D
    Wien Klin Wochenschr; 2015 Jun; 127(11-12):451-8. PubMed ID: 25854911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.
    Mahadeva S; Mahfudz AS; Vijayanathan A; Goh KL; Kulenthran A; Cheah PL
    J Dig Dis; 2013 Nov; 14(11):604-10. PubMed ID: 23859493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.
    Yoneda M; Suzuki K; Kato S; Fujita K; Nozaki Y; Hosono K; Saito S; Nakajima A
    Radiology; 2010 Aug; 256(2):640-7. PubMed ID: 20529989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty liver disease in renal transplant recipients proven by transient elastography.
    Mikolasevic I; Racki S; Lukenda V; Milic S; Pavletic-Persic M; Orlic L
    Transplant Proc; 2014 Jun; 46(5):1347-52. PubMed ID: 24836834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.